Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D2YT5I
|
|||
| Drug Name |
ADP-A2M4
|
|||
| Indication | Synovial sarcoma [ICD-11: 2B5A; ICD-9: 171] | Phase 2 | [1] | |
| Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199] | Phase 1 | [2] | ||
| Company |
Adaptimmune
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Melanoma-associated antigen 4 (MAGEA4) | Target Info | . | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Adaptimmune. | |||
| REF 2 | Clinical pipeline report, company report or official report of Adaptimmune. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.